[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338559-105":59,"doc-detail-338559-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","proteomic-analysis-of-non-muscle-invasive-and-muscle-invasive-bladder-cancer-highlights-distinct-subgroups-with-metabolic-matrisomal-and-immune-hallmarks-and-emphasizes-importance-of-the-stromal-compartment","Proteomic analysis of non-muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartment","","Proteomic profiling of 79 bladder cancers delineates molecular differences across non-muscle-invasive (NMIBC, n=17), muscle-invasive (MIBC, n=51), and neoadjuvant-treated MIBC (n=11) groups. Using data-independent acquisition on formalin-fixed, paraffin-embedded samples, analysis quantified over 8,000 proteins and mapped subtype-resolved signatures in metabolism, extracellular matrix (matrisome), and immune programs. MIBC reveals extracellular matrix and immune responses with metabolic proteome changes, while neoadjuvant therapy does not consistently alter residual tumor proteomics. NMIBC shows two proteomic subgroups linked to histological grade, and treatment-naïve MIBC displays three subgroups resembling basal-squamous, stroma-rich, and luminal patterns with immune-depleted, immune/ECM-enriched, and macrophage/dendritic cell–associated microenvironments, supporting tumor–stroma interaction roles.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/proteomic-analysis-of-non-muscle-invasive-and-muscle-invasive-bladder-cancer-highlights-distinct-subgroups-with-metabolic-matrisomal-and-immune-hallmarks-and-emphasizes-importance-of-the-stromal-compartment/338559/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/proteomic-analysis-of-non-muscle-invasive-and-muscle-invasive-bladder-cancer-highlights-distinct-subgroups-with-metabolic-matrisomal-and-immune-hallmarks-and-emphasizes-importance-of-the-stromal-compartment/338559.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How many bladder cancer samples were analyzed, and how were proteins quantified?","Question",{"text":113,"@type":114},"Proteomic profiling covered 79 bladder cancers, including NMIBC, MIBC, and neoadjuvant-treated MIBC. Proteins were extracted from formalin-fixed, paraffin-embedded samples and analyzed using data-independent acquisition, yielding more than 8,000 quantified proteins.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What proteomic differences distinguish MIBC from NMIBC?",{"text":118,"@type":114},"MIBC shows extracellular matrix and immune response signatures and metabolic proteome alterations compared with NMIBC. It also includes depletion of proteins involved in cell–cell adhesion and lipid metabolism.",{"name":120,"@type":111,"acceptedAnswer":121},"Did neoadjuvant treatment consistently change the residual tumor proteome?",{"text":122,"@type":114},"No. Neoadjuvant treatment did not consistently impact the proteome of the residual tumor mass.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338559,1790027387,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Journal of Pathology  \nJ Pathol January 2025; 265: 41–56  \nPublished online 25 November 2024 in Wiley Online Library (wi[leyonlinelibrary.com](leyonlinelibrary.com) DOI: 10.1002/path.6367)[)](leyonlinelibrary.com) DOI: 10.1002/path.6367)[ DOI:](leyonlinelibrary.com) DOI: 10.1002/path.6367)[ 10.1002/path.6367](leyonlinelibrary.com) DOI: 10.1002/path.6367)  \nORIGINAL ARTICLE  \nProteomic analysis of non-muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartment  \nThien-Ly Julia Dinh 1,2 , Manuel Rogg 1 , Miguel Cosenza-Contreras 1,2, Mujia Li 1,3, Max Zirngibl 1 , Niko Pinter 1 , Konrad Kurowski 1 , Frank Hause 1,4,5, Lena Pauli 1 , Fiona Imberg 1 , Alana Huynh 1 , Marlene Schmid 1 , Ievgen Glavinsky 1 , Luisa Braun 1 , Clara Van Wymersch 1 , Luise Bergmann 1 , Xenia Ungefug 1 , Marion Kunz 1 , Tilman Werner 1,2,6, Patrick Bernhard 1,2,6, Guadalupe Espadas7,8, Eva Brombacher2,6,9,10, Julia Schueler 11 , Eduard Sabido7,8, Clemens Kreutz9,10, Christian Gratzke 12, Martin Werner 1,13, Markus Grabbert 12, Peter Bronsert 1 , Christoph Schell 1 and Oliver Schilling 1,13*  \n1 Institute for Surgical Pathology, Faculty of Medicine, Medical Center—University of Freiburg, University of Freiburg, Freiburg, Germany  \n2 Faculty of Biology, University of Freiburg, Freiburg, Germany  \n3 Institute of Pharmaceutical Sciences, University of Freiburg, Freiburg, Germany  \n4 Department of Pharmaceutical Chemistry and Bioanalytics, Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle, Germany  \n5 Bellvitge Institute for Biomedical Research (IDIBELL), L ’Hospitalet del Llobregat, Barcelona, Spain  \n6 Spemann Graduate School of Biology and Medicine, Freiburg, Germany  \n7 Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain  \n8 University Pompeu Fabra, Barcelona, Spain  \n9 Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center – University of Freiburg, Freiburg, Germany  \n10 Centre for Integrative Biological Signalling Studies (CIBSS), University of Freiburg, Freiburg, Germany  \n11 Charles River Laboratories Germany GmbH, Freiburg, Germany  \n12 Department of Urology, Faculty of Medicine, Medical Center—University of Freiburg, University of Freiburg, Freiburg, Germany  \n13 German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany  \n*Correspondence to: O Schilling, Institute for Surgical Pathology, Faculty of Medicine, Breisacher Strasse 115a, 79106 Freiburg, Germany. E-mail: [oliver.schilling@uniklinik-freiburg.de](oliver.schilling@uniklinik-freiburg.de)  \nAbstract  \nWe present the proteomic proﬁling of 79 bladder cancers, including treatment-naïve non-muscle-invasive bladder cancer (NMIBC, n = 17), muscle-invasive bladder cancer (MIBC, n = 51), and neoadjuvant-treated MIBC (n = 11) . Proteins were extracted from formalin-ﬁxed, parafﬁn-embedded samples and analyzed using dataindependent acquisition, yielding >8,000 quantiﬁed proteins. MIBC, compared to NMIBC, shows an extracellular matrix (ECM) and immune response signature as well as alteration of the metabolic proteome together with concomitant depletion of proteins involved in cell–cell adhesion and lipid metabolism. Neoadjuvant treatment did not consistently impact the proteome of the residual tumor mass. NMIBC presents two proteomic subgroups that correlate with histological grade and feature signatures of cell adhesion or lipid/DNA metabolism. Treatmentnaïve MIBC presents three proteomic subgroups with resemblance to the basal-squamous, stroma-rich, or luminal subtypes and signatures of metabolism, immune functionality, or ECM. The metabolic subgroup presents an immune-depleted microenvironment, whereas the ECM and immune subgroups are enriched for markers of M2-like tumor-associated macrophages and dendritic cells. Markers for natural killer cells are exclusive for t","cbCaiq5EBHeIzlD4","https://ap.wps.com/l/cbCaiq5EBHeIzlD4","pdf",18967805,16,"English","# Abstract\n# Introduction\n## Clinical background: NMIBC vs MIBC\n## Treatment options and outcomes","[{\"question\":\"How many bladder cancer samples were analyzed, and how were proteins quantified?\",\"answer\":\"Proteomic profiling covered 79 bladder cancers, including NMIBC, MIBC, and neoadjuvant-treated MIBC. Proteins were extracted from formalin-fixed, paraffin-embedded samples and analyzed using data-independent acquisition, yielding more than 8,000 quantified proteins.\"},{\"question\":\"What proteomic differences distinguish MIBC from NMIBC?\",\"answer\":\"MIBC shows extracellular matrix and immune response signatures and metabolic proteome alterations compared with NMIBC. It also includes depletion of proteins involved in cell–cell adhesion and lipid metabolism.\"},{\"question\":\"Did neoadjuvant treatment consistently change the residual tumor proteome?\",\"answer\":\"No. Neoadjuvant treatment did not consistently impact the proteome of the residual tumor mass.\"}]","Proteomic analysis of non-muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartment | PDF",1790024237,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f0c97239ca6094b4134545d4ff77128.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0017d74be189f81d6bb031629a80b985.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8ddad4cfacaa954804ba63bd9029bdb.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1fe45e47d701b615e2c964d645396844.webp",980,1385]